Nyxoah has introduced its Genio neurostimulator, which is intended for obstructive sleep apnoea (OSA) treatment in England, with the first two implants carried out at University College London ...
A rheumatoid arthritis patient has become the first of five to be implanted ... the neurostimulator and the development of the controlling software. Now, the start of human trials now means ...
Medical technology company Nyxoah has officially launched its Genio system, a small implant that has the ... The system, which consists of a neurostimulator, an activation chip, a charger and ...
Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients ...